John Lewis offering in-store blood tests that could help drive down NHS waiting lists.

Home - Archives for Jordan Doherty

John Lewis offering in-store blood tests that could help drive down NHS waiting lists.

Retail giant John Lewis is to offer customers in-store blood tests in an unprecedented rollout across stores that could help drive down NHS waiting lists. The company has partnered with diagnostics firm Randox in a novel programme which will offer customers health checks, including those for certain cancers, diabetes and heart disease.

It is believed to be the first time blood tests are offered in department stores and follows the success of a pilot scheme last winter.

The news comes as Randox launches a suite of new blood tests which it says can pick up markers for some cancers at an early stage.

Randox has been in talks with senior NHS officials urging them to adopt its pioneering technology that identify abnormalities using a special microchip.

It believes its novel ‘lab on a chip’ tests for prostate, bladder and gastrointestinal cancers could cut the NHS waiting list by reducing the number of patients having to undergo invasive and sometimes painful diagnostic tests. This could include cystoscopies – the procedure that King Charles was likely to have undergone as part of investigations into his prostate condition.

NHS officials have been given data showing up to 2.2 million people could be lifted off the waiting list and £3 billion a year saved if the Randox blood cancer tests were routinely used in the NHS. Ministers are said to be examining the findings.

Checks for vitamin and mineral deficiencies, fertility and hormonal health as well as genetic testing for disease are also being offered.

Blood samples are sent to labs and results are sent back to clients who are able to book post-report consultations.

Naomi Simcock, Executive Director, John Lewis, said customers are “increasingly seeking personalised, preventative health and wellbeing care.”

She added: “Our stores can play an important role by making vital services like healthcare more convenient and accessible.”

Dr Peter FitzGerald, Managing Director of Randox Health said: “Our comprehensive testing packages provide the foundation for individuals to take greater control of their health and optimise the potential to live well for longer. Randox’s presence in John Lewis stores will increasingly improve accessibility to leading healthcare prevention and wellbeing.”

A government spokesman said: “We have already made available £2.3 billion in capital investment over three years to transform diagnostic services, including improving digital diagnostic capabilities, and we have opened 153 community diagnostic centres, delivering more than six million additional scans to date.

“The NHS carefully considers any treatment or procedure proven to improve or speed up diagnosis.”

Words by Lucy Johnston, Health and Social Affairs Editor of the Sunday Express 

John Lewis to offer in-store blood tests to millions of Brits to help slash NHS waitlist | Express.co.uk


King Charles’ recent cancer diagnosis highlights the importance of early detection.

King Charles’ recent cancer diagnosis has highlighted the importance of early detection. By detecting potential health issues early at Randox Health, individuals can implement lifestyle changes, treatment plans, or preventative measures that might help mitigate or event prevent the progression of certain diseases.

At Randox Health, we deliver the information to empower people to be proactive about improving their health and well-being.

Using novel biomarker-based algorithms, Randox Health deliver real-time information on cancer risk e.g., prostate cancer and bladder cancer, allowing earlier intervention and treatment.

Traditionally, prostate cancer risk assessment involves PSA testing. PSA measures the level of Prostate Specific Antigen in the blood and can indicate abnormality within the prostate.

Although PSA is highly specific for prostate disease, it is not specific for prostate cancer. A raised PSA can also indicate an enlarged prostate, prostatitis, or a urinary tract infection.

The new Randox Health Prostate Cancer Risk algorithm combines traditional PSA testing, with analysis of novel biomarkers to help determine risk of prostate cancer. Combining biomarkers in this way can help strengthen assessment and enable those with an increased risk of prostate cancer to be prioritized for further investigation, as well as reducing the need for unnecessary and invasive further investigations in low-risk individuals.

It is estimated that 30-50% of all cancer cases are avoidable, in many cases early detection is key and can save lives – cancer that is diagnosed at an early stage, when it isn’t too large and hasn’t spread, is more likely to be treated successfully.

Spotting cancer at an early stage saves lives, many people however, don’t have access to the information or services to facilitate this detection – Over 8 million people within the UK are currently awaiting diagnostic testing. At Randox Health, with over forty years’ experience in creating new and innovative diagnostic technologies, we have a focus on early diagnosis and prevention; aiming to achieve better health outcomes whilst reducing the burden on clinical services.

At Randox Health we offer genetic risk tests for inherited cancers including Breast and Ovarian Cancer, Bowel Cancer, and others. In addition, we offer a range of full body health checks that include common tumour associated markers.

The results gained allows you to not only get a more accurate interpretation of your current health status but knowingly make lifestyle changes that can help you prevent future health risks.

 

Additional Information on tests available at Randox Health

Genetic Cancer Risk

Available from £750

1 in 10 cancers are thought to be caused by hereditary gene mutations. Our Genetic Cancer Risk test covers 94 different genes suspected to play a role in predisposing one to cancer, including genes associated with increased risk of breast, ovarian, prostate, colorectal and thyroid cancer.

If a genetic variant linked to cancer is found there are options available to help reduce the risk of developing cancer.

  • Lifestyle changes
  • Regular screening and health checks
  • In some cases – risk-reducing surgery.

Our Randox Health Genetic Counsellor will guide and support you throughout testing processes and will also be available to explain your results and advise on next steps.

Genetic Breast and Ovarian Cancer Risk

Available from £499.

Around 5-10% of breast cancer cases are thought to be hereditary and up to 20% of ovarian cancers are genetic. Our Genetic Breast and Ovarian Cancer Risk test covers 8 different genes including BRCA1 and BRCA2 associated with both hereditary breast and ovarian cancer.

Genetic Bowel Cancer Risk

Available from £499

It is estimated that 1 in 15 males and 1 in 8 females will develop bowel cancer in their lifetime with around 5-10% of all bowel cancers thought to be caused by a mutation in a known gene. Our bowel cancer risk test screens for mutations in 11 different genes associated with increased risk of bowel cancer.

Advanced PSA

Available from £49

Almost 50,000 men in the United Kingdom (UK) are diagnosed each year with prostate cancer (PCa). Secondary referrals for investigations rely on PSA levels and digital rectal examination. However, both tests lack sensitivity and specificity, resulting in unnecessary referrals to secondary care for costly and invasive biopsies.

Using a novel combination of biomarkers including PSA, our prostate Cancer Risk Score can help to assess your risk of prostate cancer and help reduce the need for unnecessary, invasive further investigations in low-risk individuals.

A recent study demonstrated that the combination of markers included within this test significantly improved the predictive potential of PSA alone in identifying individuals with prostate cancer.

Everyman/ Everywoman Plus Tumour-Associated Markers

Available from £857

With this health package you can get unrivalled insights on your overall health in addition to several tumour markers associated with bowel, ovarian, prostate, liver, and pancreatic cancer from a simple blood test. Regular health screenings helps to identify risks early allowing you to get the appropriate treatment sooner.

Signature Platinum Range

Available from £2600

Get truly unrivalled insights on your current health and future health risks that empower you to take action to help improve your health and prevent illness.

Measure 350 health data points relating to your full body health including genetic, stress, neurological & tumour associated markers with full repeat testing after 6 months is included to allow you to effectively evaluate the progress of your health journey to the fullest and identify further areas for improvement.

GPs appointments, referrals and prescriptions are included if required.


Free NHS Health Check Service for Doncaster Residents in partnership with Randox Health

 

From February 5th, eligible Doncaster residents aged between 40-70 will be able to book a free NHS health check.

The health checks aim to detect the risk of an individual having a heart attack, stroke, or developing Type 2 diabetes over the next decade. In its first five years, the NHS Health Check initiative is estimated to have prevented over 2,500 heart attacks or strokes as a result of people receiving preventative treatment following their Health Check.

Following the Health Check, the results will be made available to GP’s for inclusion on patient medical records to enable further follow-up if required. Not only does the Health Check enable prevention and mitigation through the early identification of serious illness, but it also offers onward support if required to assist with lifestyle modification on issues including smoking, alcohol, and weight management.

This service is specifically focussed on providing checks to patients at high risk, therefore selected patients will receive a letter on behalf of their GP inviting them to avail of the check. The dedicated NHS Health Check Clinic t Cussins House, 22-28 Wood Street is situated conveniently in central Doncaster benefitting from excellent accessibility and transport links. In addition to this, for those that cannot access the city centre, appointments will be provided at a range of community locations across the borough.

To check your eligibility and book an appointment please visit: NHS health Checks (randox.com)

or phone the Randox team on: 0800 2545 452

David Ferguson, Chief Operating Officer for Randox Health, said: “At Randox Health we promote preventative healthcare and action, so are delighted to be part of this initiative to bring health checks to Doncaster.

“We believe that early diagnostic health testing delivers better outcomes for individuals, relieving the pressure on our NHS by enabling lifestyle changes and medical intervention.”

Additional notes:

  • To be eligible patients must be aged between 40 and 74, live or be registered to a GP in Doncaster, and meet the criteria regarding previous conditions.
  • NHS Health Check Doncaster Address: Suite 1-05 & 1-06 Cussins House, 22-28 Wood Street, Doncaster, DN1 3LW.
  • Appointments must be booked in advance and will be available from Wednesday, 14th February.

 


Free health checks in Sandwell

 

Sandwell residents will be able to benefit from diagnostic NHS Health Checks, testing for diabetes, heart and kidney disease, and hyper tension.

After the launch of Sandwell Council’s partnership with Randox Health in 2023,which saw thousands of eligible Sandwell residents offered diagnostic NHS Health Checks, the partnership has continued – giving residents a health boost for 2024!

Free tests will be offered to Sandwell residents aged between 40 and 70 who have not previously suffered coronary heart disease, strokes, diabetes, or kidney disease. Over the next few weeks those eligible will receive letter inviting them to the 20-minute NHS Health Check, under joint branding from Randox, Healthy Sandwell and the NHS.

Tests and clinics will be available for Sandwell residents in both Sandwell and, if convenient, in Birmingham, with additional free body composition analysis for health checks completed at the Birmingham clinic. Results will be made available for GPs for review and inclusion on patient medical records.

Not only does the testing programme enable prevention and mitigation through he early identification of serious illness, but it also allows lifestyle modification on issues including smoking, alcohol, and weight management. This partnership also includes a limited number of 3-month free gym memberships.

Councillor Suzanne Hartwell, Sandwell Council’s Cabinet Member for Adults, Social Care & Health, said: “The good health of our residents has always been a priority for the Council. This initiative will have a significant and beneficial impact on the health and longevity of thousands of people living in the area. It will enable those at high risk to take medical and lifestyle steps to prevent illnesses which could, if not detected early, shorten, or change lives.”

David Ferguson, Chief Operating Officer for Randox Health said, “Randox is delighted to be part of this joint initiative with Sandwell Council’s Public Health Team. It has long been our belief that early diagnostic health testing delivers better outcomes for individuals. It relieves the pressure on our NHS by enabling lifestyle change and medical intervention. This in turn, prevents or mitigates illnesses which could otherwise require intense long-term treatment.”


Randox Health launches new partnership with leading UK retailer John Lewis

Northern Ireland headquartered diagnostics company Randox has announced an exciting new partnership with the leading UK retailer, John Lewis & Partners.

From next month John Lewis customers will be able to benefit from Randox Health’s comprehensive preventative health programmes at stores in High Wycombe, Bluewater in Dartford
and Cheltenham, with more to follow in 2024. The addition of in-store Randox Health clinics marks a natural evolution in the growing range of personalised wellness services from John Lewis.

The range of Randox Health programmes on offer to John Lewis customers are:                           

• Everyman and Everywoman which each provide up to 150 data points linked to key health
areas. A personalised health plan summarising the results is provided, with retesting
six months after the initial test.

• The Signature health programme offers 350 data points, genetic testing, and GP
consultation, and retesting after 6 months.

• Everyathlete which offers key health insights to help optimise training, and nutrition for
maximum performance.

• Specific packages focussed on preventative health, including gut, fertility, hormonal, male
and female health as well as genetic testing.

In store appointments will be undertaken within branded Randox Health facilities and consultation rooms, conducted by experienced Randox healthcare professionals.

Once samples have been analysed within Randox’s Laboratories, clients are provided with comprehensive diagnostics report within 2-5 working days of the initial appointment, including a
breakdown of results, what they mean and next steps. Alongside post-report consultations, the user-friendly report can also be shared with other medical professionals.

Naomi Simcock, Executive Director, John Lewis, said, ‘As trusted places for local communities across the country, our stores can play an important role by making vital services
like healthcare more convenient and accessible.

Coupled with this, customers are increasingly seeking personalised, preventative health and wellbeing care. In Randox we have an experienced and innovative partner to grow our range of
in-store services, to help customers proactively manage their health. Together with our range of inspirational instore services, our customers are able to enjoy an array of experiences to meet
their needs and wants.”

Dr. Peter FitzGerald, Managing Director of Randox Health said, ‘We are delighted to work together with John Lewis to bring innovative preventative healthcare directly to customers. Our
comprehensive testing packages, using Randox’s unique technologies and data analytics, provide the foundation for individuals to take greater control of their health and optimise the potential to live well for longer. Randox’s presence in John Lewis stores will increasingly improve accessibility to leading healthcare prevention and wellbeing.”

 


NHS waiting lists can fall by 2.2 million with my plan, says Dr. Peter Fitzgerald

 

Private diagnostic clinics can help end the scourge of NHS waiting lists 

By Dr. Peter Fitzgerald

NHS waiting times are one of the greatest domestic challenges facing the United Kingdom. Government has officially recognised this for some time, with the current incarnation highlighting wait times as one of the government’s top 5 priorities.

Wait times clog up the system and can mean potentially lifesaving early diagnosis are missed simply because there is too much time between people going to the doctor and the results coming back. Worse, can be the wait times between referral’s to specialists or just regular hospitals.

However, we have a solution that will revolutionize the system. By embracing preventative medicine in a revitalised partnership between the NHS and the private sector we could cut waiting lists by millions and save the taxpayer billions of pounds.

By integrating diagnostic clinics, which were used to great affect during the Covid pandemic, we would be able to diagnose serious illnesses, diseases or other health problems long before they become symptomatic.

Private testing clinics can already deliver clear and accurate results in less than a day, usually only a few hours. This far outstrips the week-long norm in the NHS. This would allow GPs to have far faster turnaround times for patients and quicker assessment of patient needs.

Critically, modern testing techniques enable experts to test for a wide variety of potential illnesses from a single small blood or urine sample and so spot problems before a patient becomes ill, making it possible for successful medical or surgical intervention.

The adage of prevention being better than a cure may not truly work here but every medical professional will tell you that an early diagnosis drastically improves a patient’s outcomes. Early diagnosis normally reduces both the financial cost and the health cost to a patient.

By outsourcing testing to the private sector – under a rigorous independent tendering process – the NHS can be freed up to get on with its prime job of treating the sick.

Under our proposals, the public would be invited to visit a private diagnostic clinic every year for a check-up. Results would be monitored by in house scientists who would advise people on next steps.  Results would be routinely passed onto GPs, though in many cases no further action would be needed.

GPs would ultimately decide on medical interventions and possible referral to NHS hospital services. A priority group for such tests would be the 7.7 million on NGS waiting lists. They would be assessed to see if their condition had worsened and whether urgent action was required.

We estimate that by embracing private testing technology, the government could save the NHS £3 billion a year and reduce the waiting list backlog by around 2.2 million people.


David Davis calls for blanket testing to save NHS £3bn a year

 

Ministers are being urged to introduce mass medical testing to cut NHS costs by billions and save thousands of lives.

Former Brexit Secretary David Davis calls for mass medical testing across the whole UK population by companies which he believes will alert the NHS to potential health risks for individuals and allow for lifestyle changes and treatment before problems become serious.

Mr. Davis said, “I bring it back to the reality of individuals. If we delay diagnosis, we delay treatment – we sentence people to death. It’s as harsh as that. So one of the things I would like to see us do is dramatically increase the amount of diagnostic capacity we have.”

“My view is that actually we should break clear of the ideology. We should look to increase dramatically the amount of scans and diagnostic procedures we can create. And when I say dramatically, I mean a multiple of what we currently do and we should use the private sector to do it.

“I know it causes a bridling and a backing off but I the only way we can do it fast enough is to do that. And that will save I think about £3 billion, get the waiting lists down by millions of people but most importantly of all will save thousands of lives.”

Mr. Davis was reacting to a paper drawn up by Northern Ireland medical testing company Randox, one of the private health providers who developed Covid testing during lockdown. The paper has been drawn up by scientists at Randox, scaling up its testing capacity from 300 tests a day to 120,000 a day in less than 12 months. Overall, the firm conducted nearly 27 million tests during the pandemic.

Dr. Peter Fitzgerald, the founder of Randox, said that with the NHS waiting lists not far short of eight million people and with budgets under intense pressure, the time had come for a new partnership between the public and private sectors.

Ministers should start by convening a summit of private diagnostic firms and their NHS counterparts and investigate the potential of the enormous advances in testing technologies developed in recent years. By harnessing the startling progress made by scientists they could revolutionize standards of health care while slashing waiting lists and achieving far greater value for money.

Dr. Fitzgerald added, “Policy-makers need to appreciate the vast potential of the latest diagnostic testing technologies. They can deliver a step-change in the quality of people’s lives. By outsourcing much testing to the private sector – under a rigorous independent tendering process – the NHS can be freed up to  get on with its prime job of treating the sick.”

Under the Randox plan, the public would be invited to visit a private diagnostic clinic every year for a check-up. Results would be monitored in house by scientists who would advise people on next steps. Results would be routinely passed onto their GPs, though in many cases no further action would be needed.

GPs would ultimately decide on medical interventions and possible referral to NHS hospital services. A priority group for such tests would be the 7.7 million on NHS waiting lists. They would be assessed to see if their condition had worsened and whether urgent action was required.

High-tech comprehensive testing of the population would also reduce if not eliminate the many false positives arising from much of the diagnostic services available today.

Taken from Daily Express article by David Maddox, Political Editor.

Randox welcomed the Queen’s University staff Leadership Team to their Antrim based Randox Science Park in Antrim.

Randox were delighted to welcome the Queen’s University Belfast Leadership Team to their Antrim based headquarters, Randox Science Park on Tuesday, October 4th.

President and Vice Chancellor, Sir Ian Greer of Queen’s University was joined by Deputy Vice-Chancellor Professor Stuart Elborn, Head of Careers, Employability and Skills Mr Trevor Johnston, Head of Business Alliance Mr Dermot Leonard, Business Engagement Manager Mrs Joanne Mallon, Executive Director of the Global Innovation Institute Dr. David Quinn, Lead of Queen’s sustainable energy research Professor David Rooney, Dean of Research in Medicine, Health and Life Sciences Professor David Rooney, Dean of Research in Medicine, Health and, Life Sciences Professor Chris Scott, and Dean of Impact and Innovation in Medicine, Health, and Life Sciences.

The team received a presentation on Randox’s capabilities which stimulated multiple discussions in relation to research, improvements in healthcare provision, skills and the exciting future of Life and Health Sciences in Northern Ireland.

The purpose-built facilities at the site, covering research and development, engineering, manufacturing and accredited laboratories provides an unparalleled depth of diagnostic capability within a single site.

Randox employ over 2,200 staff, including 800 research scientists and engineers – all focused on improving life science diagnostic capabilities globally.

More than 5% of the world’s population (over 400 million people) receive medical diagnosis using Randox products each year. Randox have major facilities in the UK, Ireland, India, and the United States, supported by global distribution and supply networks.

 


Secretary of State visit to Randox Science Park

The Rt Hon Chris Heaton-Harris, Secretary of State for Northern Ireland paid a visit to Randox Science Park on Thursday, October 19th, to discuss Randox capabilities and undertake a tour of the facilities at the Antrim site.

As leading diagnostic company from the UK & Ireland, Randox have spent over forty years improving healthcare,  with a focus on the provision of timely and accurate  testing both to improve clinical diagnosis and promote preventative healthcare.

The purpose-built facilities at the site, covering research and development, engineering, manufacturing and accredited laboratories provides an unparalleled depth of diagnostic capability with a single site.

More than 5% of the world’s population (over 400 million people) receive medical diagnosis using Randox products each year.

Randox’s proprietary Biochip Technology is the result of a £350 million investment, allowing many tests to be run simultaneously, greatly improving the diagnostic power available to clinicians. This innovative technology allowed the provision of advanced health  profiling to support both early diagnosis and the transition to preventative healthcare.

Randox Science Park is a central hub of Randox’s life science manufacturing, engineering and research and development. Randox employ over 2,200 staff, including 800 research scientists and

engineers – all focused on improving life science diagnostic capabilities globally.

Randox Science Park is one of four key manufacturing and development sites, with others located in Dungloe, County Donegal; Bangalore, India; and the Greater Washington DC area, USA. Across the UK & Ireland there is also a growing network of Randox Health Clinics.

 

 


Look after your gut and it will look after you – Goodwood Health Summit 2023

At long last the public is cottoning on to the simple but important notion of preventative health – the idea that you don’t go to the doctor after falling ill – you go before so that potential future illnesses can be identified in advance and action taken immediately.

Randox, a leader in the field of diagnostic medicine, is in the forefront of this profound change in health care – one that opens up the possibility of delivering enormous benefits to individuals and society at large.

For these reasons, we were delighted to lend our support to the recent launch of the Goodwood Gut Summit hosted by the Goodwood Estate. The summit theme was on gut microbiomes, which play a key role in promoting the smooth daily operations of our body. Broadcast online, the summit aimed to respond to the urgent need for widespread education and communication about rapid progress in dietary health.

The summit came after a stark warning contained in two landmark studies into the effects of ultra-processed foods on our diet and its effect on our microbiomes.

This newly published research concluded that eating ultra-processed foods – such as ready meals, fizzy juice, cereals, and fast food – drastically increases our risk of serious health issues, such as high blood pressure and diabetes. It can also raise the risk of heart attacks and strokes. BBC journalist Justin Webb led the conversation with a world-class line-up of speakers, including, Dr Chris van Tulleken, Jessie Inchauspé, Dr James Kinross, Professor Pekka Puska and Professor Edward Bullmore.

Topics covered included inflammation, mental health and the microbiome , insulin, obesity, ultra-processed foods , the growing cost of poor nutrition, and the need to drive fundamental shifts in our food systems in order to move to a healthier future for all.

There was a discussion on using the many curbs on the promotion and sale of tobacco as a model for the food industry. Tighter regulation of food manufacturers and their marketing strategies could be the way forward here. As authorities in their respective fields, the speakers shared their knowledge and vision on these important topics, as well as considered new solutions to personal and societal health challenges, helping the formulation of some key achievable goals.

The partnership with the summit is underpinned by two Randox Laboratory divisions.

Randox Food Diagnostics is dedicated to improving the global food security chain. It provides the global food market with screening solutions for antimicrobials, toxins, growth-promoting hormones and veterinary drugs in animals and animal produce, as well as testing meat, milk, honey, grapes, seafood and feed products.

Food product testing is essential to ensure that what we consume is safe from physical, chemical, and biological hazards. It tells people precisely what they are eating and so helps them make informed choices and makes sure that goods on the supermarket shelves comply with safety standards.

Randox Health, the consumer-facing side of Randox Laboratories, is primarily focused on accessible, preventative health testing and offers full body health checks that identify early signs of disease before symptoms occur.

 

What is gut microbiome?

Picture a bustling city on a weekday morning, the pavements flooded with people rushing to get to work or to appointments. Now imagine this at a microscopic level and you have an idea of what the microbiome looks like inside our bodies, consisting of trillions of microorganisms (also called microbiota or microbes) of thousands of different species.

These include not only bacteria but fungi, parasites, and viruses. In a healthy person, these “bugs” coexist peacefully, with the largest numbers found in the small and large intestines but also throughout the body. The microbiome is even labeled a supporting organ because it plays so many key roles in promoting the smooth daily operations of the human body.

A person is first exposed to microorganisms as an infant, during delivery in the birth canal and through the mother’s breast milk. Later on, environmental exposures and diet can change our microbiomes to be either beneficial to health or to place one at greater risk for disease. Read more about it here(https://www.hsph.harvard.edu/nutritionsource/microbiome/)

More info on Randox Food Diagnostics: Randox food diagnostics-randoxfood.com

To book a health test please follow the link below; Randox Health-randoxhealth.com

Book your stay at the Goodwood Gut Health programme, that includes a Randox panel of testing; www.goodwood.com/visit-eat-stay/health-wellbeing/wellness-retreats/gut-health-programme/


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×